Literature DB >> 789764

Modified Vi tests in the screening of typhoid carriers.

P Y Chau, A C Chan.   

Abstract

Two tests for the estimation of Vi antibody in sera were studied and their validity in the screening of typhoid carriers was assessed. One was a modified Vi haemagglutination test in which Vi-coated glutaraldehyde-fixed erythrocytes were used as the antigen and Vi antibody resistant to treatment with 2-mercaptoethanol was titrated. The other was a fluorescent Vi antibody test in which acetone-fixed bacterial Vi cells were used as the antigen and the total Vi antibody was titrated. In both tests, the antigens used were stable so that standardization of the tests would not be difficult. The modified Vi haemagglutination test was found equally sensitive but more specific in giving less false positives than the conventional Vi haemagglutination test. The fluorescent Vi antibody test was however found superior to both tests not only in giving less false positives but also in detecting more typhoid carriers.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 789764      PMCID: PMC2129716          DOI: 10.1017/s002217240005556x

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  9 in total

1.  A CHALLENGE TO THE VALIDITY OF THE VI TEST FOR THE DETECTION OF CHRONIC TYPHOID CARRIERS.

Authors:  V BOKKENHEUSER; P SMIT; N RICHARDSON
Journal:  Am J Public Health Nations Health       Date:  1964-09

2.  Estimation of Vi antibody employing erythrocytes treated with purified Vi antigen.

Authors:  M LANDY; E LAMB
Journal:  Proc Soc Exp Biol Med       Date:  1953-04

3.  Sensitized and stabilized red blood cells coated with Vi antigen as a sensitive tool for the detection of Vi agglutinins.

Authors:  M Eskenazy; R Cohen
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1974-12

4.  Study on the production of IgG, IgA- and IgM-antibodies to somatic antigens of Salmonella typhi in humans.

Authors:  E Chernokhvostova; K I Luxemburg; V Starshinova; N Andreeva; G German
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

5.  Isolation of Vi antigen and a simple method for its measurement.

Authors:  K H Wong; J C Feeley
Journal:  Appl Microbiol       Date:  1972-10

6.  Vi reaction in Hong Kong.

Authors:  C R Forrest; R N Matthews; M J Robertson; W P Hanley
Journal:  Br Med J       Date:  1967-05-20

7.  Significance of the V-I haemagglutination test.

Authors:  G N Cooper; J N Singh
Journal:  Med J Aust       Date:  1965-10-30       Impact factor: 7.738

8.  Agglutinating and precipitating capacity of rabbit anti-Salmonella typhosa gamma G and gamma M-antibodies during prolonged immunization.

Authors:  R M Pike; M L Schulze; C H Chandler
Journal:  J Bacteriol       Date:  1966-10       Impact factor: 3.490

9.  THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES.

Authors:  J B ROBBINS; K KENNY; E SUTER
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

  9 in total
  6 in total

1.  Waterborne infectious disease in Britain.

Authors: 
Journal:  J Hyg (Lond)       Date:  1978-08

2.  Vi serology in screening of typhoid carriers: improved specificity by detection of Vi antibodies by counterimmunoelectrophoresis.

Authors:  P Y Chau; R S Tsang
Journal:  J Hyg (Lond)       Date:  1982-10

3.  Comparison of the Vi indirect fluorescent antibody test with the Widal agglutination method in the serodiagnosis of typhoid fever.

Authors:  N Doshi; A G Taylor
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

4.  Enzyme-linked immunosorbent assay for detection of human antibodies to Salmonella typhi Vi antigen.

Authors:  T J Barrett; P A Blake; S L Brown; K Hoffman; J M Llort; J C Feeley
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

5.  Evaluation of a new assay for Vi antibody in chronic carriers of Salmonella typhi.

Authors:  C M Nolan; J C Feeley; P C White; E A Hambie; S L Brown; K H Wong
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

6.  Production of Vi monoclonal antibodies and their application as diagnostic reagents.

Authors:  R S Tsang; P Y Chau
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.